Anabolic steroid definition

Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related
Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone.
Anabolic steroid means any drug or hormonal substance chemically and pharmacologically related to testosterone that promotes muscle growth and includes those substances listed in KRS 218A.090(5) but does not include estrogens, progestins, and anticosteroids;

More Definitions of Anabolic steroid

Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestins, and corticosteroids, that promotes muscle growth.
Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestin, and corticosteroid that promotes muscle growth.
Anabolic steroid means any drug or hormonal substance as defined in s. 961.01 (2m) (a), Stats.
Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestins, corticosteroids, or dehydroepiandrosterone, which substance is identified as an anabolic steroid in section 124.208, subsection 6, and includes any other substance designated by the board as an anabolic steroid through the adoption of rules pursuant to chapter 17A.
Anabolic steroid means any drug or hormonal substance chemically and pharmacologically related to testosterone that promotes muscle growth and includes those substances classified as Schedule III controlled substances pursuant to KRS 218A.020 but does not include estrogens, progestins, and anticosteroids;
Anabolic steroid means any drug or hormonal substance chemically and
Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related 1130 to testosterone, other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone. 1131 "Animal" means any nonhuman animate being endowed with the power of voluntary action. 1132 "Automated drug dispensing system" means a mechanical or electronic system that performs 1133 operations or activities, other than compounding or administration, relating to pharmacy services, 1134 including the storage, dispensing, or distribution of drugs and the collection, control, and maintenance of 1135 all transaction information, to provide security and accountability for such drugs. 1136 "Biological product" means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood 1137 component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or 1138 analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic 1139 arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human 1140 beings. 1141 "Biosimilar" means a biological product that is highly similar to a specific reference biological 1142 product, notwithstanding minor differences in clinically inactive compounds, such that there are no 1143 clinically meaningful differences between the reference biological product and the biological product that 114411451146 has been licensed as a biosimilar pursuant to 42 U.S.C. § 262(k) in terms of safety, purity, and potency of the product."Board" means the Board of Pharmacy. 1147 "Bulk drug substance" means any substance that is represented for use, and that, when used in the 1148 compounding, manufacturing, processing, or packaging of a drug, becomes an active ingredient or a 1149 finished dosage form of the drug; however, "bulk drug substance" shall not include intermediates that 1150 are used in the synthesis of such substances. 1151 "Change of ownership" of an existing entity permitted, registered, or licensed by the Board means (i) 1152 the sale or transfer of all or substantially all of the assets of the entity or of any corporation that owns 1153 or controls the entity; (ii) the creation of a partnership by a sole proprietor, the dissolution of a 1154 partnership, or change in partnership composition; (iii) the acquisition or disposal of 50 percent or more